ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Echinocandins Antifungal Drugs Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-36C16340
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Echinocandins Antifungal Drugs Market Research Report 2023
BUY CHAPTERS

Global Echinocandins Antifungal Drugs Market Research Report 2025

Code: QYRE-Auto-36C16340
Report
June 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Astellas
Endo International
Xellia Pharmaceuticals
TEVA
Hikma
Apotex
Fresenius
Pfizer Inc
CTTQ
Qilu Pharmaceutical
BrightGene Bio-Medical Technology
Hansoh Pharmaceutical

Echinocandins Antifungal Drugs Market Size

The global market for Echinocandins Antifungal Drugs was valued at US$ 1089 million in the year 2024 and is projected to reach a revised size of US$ 1381 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Echinocandins Antifungal Drugs Market

Echinocandins Antifungal Drugs Market

Echinocandins are a class of antifungal drugs that inhibit the synthesis of β-glucan in the fungal cell wall via noncompetitive inhibition of the enzyme 1,3-β glucan synthase. The class has been termed the "penicillin of antifungals," along with the related papulacandins, as their mechanism of action resembles that of penicillin in bacteria.
Echinocandins are a class of antifungal medications administered through injection, widely used to treat severe fungal infections. These drugs target the β-1,3-glucan synthase enzyme in the fungal cell wall, leading to the inhibition of cell wall synthesis and subsequent fungal cell death. Common echinocandins include caspofungin, anidulafungin, and micafungin, often utilized in the treatment of refractory candidiasis such as invasive candidiasis. They typically require strict medical supervision and judicious use due to their lower toxicity targeting fungal cell wall synthesis, making them an important choice in combating fungal infections.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Echinocandins Antifungal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Echinocandins Antifungal Drugs.
The Echinocandins Antifungal Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Echinocandins Antifungal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Echinocandins Antifungal Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Echinocandins Antifungal Drugs Market Report

Report Metric Details
Report Name Echinocandins Antifungal Drugs Market
Accounted market size in year US$ 1089 million
Forecasted market size in 2031 US$ 1381 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Caspofungin
  • Micafungin
  • Anidulafungin
Segment by Application
  • Hospital
  • Drugstore
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Astellas, Endo International, Xellia Pharmaceuticals, Teva, Hikma, Apotex, Fresenius, Pfizer, CTTQ, QILU Pharmaceutical, BrightGene Bio-Medical Technology, Hansoh Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Echinocandins Antifungal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Echinocandins Antifungal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Echinocandins Antifungal Drugs Market growing?

Ans: The Echinocandins Antifungal Drugs Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Echinocandins Antifungal Drugs Market size in 2031?

Ans: The Echinocandins Antifungal Drugs Market size in 2031 will be US$ 1381 million.

Who are the main players in the Echinocandins Antifungal Drugs Market report?

Ans: The main players in the Echinocandins Antifungal Drugs Market are Merck, Astellas, Endo International, Xellia Pharmaceuticals, Teva, Hikma, Apotex, Fresenius, Pfizer, CTTQ, QILU Pharmaceutical, BrightGene Bio-Medical Technology, Hansoh Pharmaceutical

What are the Application segmentation covered in the Echinocandins Antifungal Drugs Market report?

Ans: The Applications covered in the Echinocandins Antifungal Drugs Market report are Hospital, Drugstore

What are the Type segmentation covered in the Echinocandins Antifungal Drugs Market report?

Ans: The Types covered in the Echinocandins Antifungal Drugs Market report are Caspofungin, Micafungin, Anidulafungin

Recommended Reports

Antifungal Drugs

Fungal Infection Therapies

Antifungal Diagnostics

1 Echinocandins Antifungal Drugs Market Overview
1.1 Product Definition
1.2 Echinocandins Antifungal Drugs by Type
1.2.1 Global Echinocandins Antifungal Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Caspofungin
1.2.3 Micafungin
1.2.4 Anidulafungin
1.3 Echinocandins Antifungal Drugs by Application
1.3.1 Global Echinocandins Antifungal Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drugstore
1.4 Global Echinocandins Antifungal Drugs Market Size Estimates and Forecasts
1.4.1 Global Echinocandins Antifungal Drugs Revenue 2020-2031
1.4.2 Global Echinocandins Antifungal Drugs Sales 2020-2031
1.4.3 Global Echinocandins Antifungal Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Echinocandins Antifungal Drugs Market Competition by Manufacturers
2.1 Global Echinocandins Antifungal Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Echinocandins Antifungal Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Echinocandins Antifungal Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Echinocandins Antifungal Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Echinocandins Antifungal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Echinocandins Antifungal Drugs, Product Type & Application
2.7 Global Key Manufacturers of Echinocandins Antifungal Drugs, Date of Enter into This Industry
2.8 Global Echinocandins Antifungal Drugs Market Competitive Situation and Trends
2.8.1 Global Echinocandins Antifungal Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Echinocandins Antifungal Drugs Players Market Share by Revenue
2.8.3 Global Echinocandins Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Echinocandins Antifungal Drugs Market Scenario by Region
3.1 Global Echinocandins Antifungal Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Echinocandins Antifungal Drugs Sales by Region: 2020-2031
3.2.1 Global Echinocandins Antifungal Drugs Sales by Region: 2020-2025
3.2.2 Global Echinocandins Antifungal Drugs Sales by Region: 2026-2031
3.3 Global Echinocandins Antifungal Drugs Revenue by Region: 2020-2031
3.3.1 Global Echinocandins Antifungal Drugs Revenue by Region: 2020-2025
3.3.2 Global Echinocandins Antifungal Drugs Revenue by Region: 2026-2031
3.4 North America Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.4.1 North America Echinocandins Antifungal Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Echinocandins Antifungal Drugs Sales by Country (2020-2031)
3.4.3 North America Echinocandins Antifungal Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.5.1 Europe Echinocandins Antifungal Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Echinocandins Antifungal Drugs Sales by Country (2020-2031)
3.5.3 Europe Echinocandins Antifungal Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Echinocandins Antifungal Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Echinocandins Antifungal Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Echinocandins Antifungal Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Echinocandins Antifungal Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.7.1 Latin America Echinocandins Antifungal Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Echinocandins Antifungal Drugs Sales by Country (2020-2031)
3.7.3 Latin America Echinocandins Antifungal Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Echinocandins Antifungal Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Echinocandins Antifungal Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Echinocandins Antifungal Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Echinocandins Antifungal Drugs Sales by Type (2020-2031)
4.1.1 Global Echinocandins Antifungal Drugs Sales by Type (2020-2025)
4.1.2 Global Echinocandins Antifungal Drugs Sales by Type (2026-2031)
4.1.3 Global Echinocandins Antifungal Drugs Sales Market Share by Type (2020-2031)
4.2 Global Echinocandins Antifungal Drugs Revenue by Type (2020-2031)
4.2.1 Global Echinocandins Antifungal Drugs Revenue by Type (2020-2025)
4.2.2 Global Echinocandins Antifungal Drugs Revenue by Type (2026-2031)
4.2.3 Global Echinocandins Antifungal Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Echinocandins Antifungal Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Echinocandins Antifungal Drugs Sales by Application (2020-2031)
5.1.1 Global Echinocandins Antifungal Drugs Sales by Application (2020-2025)
5.1.2 Global Echinocandins Antifungal Drugs Sales by Application (2026-2031)
5.1.3 Global Echinocandins Antifungal Drugs Sales Market Share by Application (2020-2031)
5.2 Global Echinocandins Antifungal Drugs Revenue by Application (2020-2031)
5.2.1 Global Echinocandins Antifungal Drugs Revenue by Application (2020-2025)
5.2.2 Global Echinocandins Antifungal Drugs Revenue by Application (2026-2031)
5.2.3 Global Echinocandins Antifungal Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Echinocandins Antifungal Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Echinocandins Antifungal Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Astellas
6.2.1 Astellas Company Information
6.2.2 Astellas Description and Business Overview
6.2.3 Astellas Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Astellas Echinocandins Antifungal Drugs Product Portfolio
6.2.5 Astellas Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Company Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Endo International Echinocandins Antifungal Drugs Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Xellia Pharmaceuticals
6.4.1 Xellia Pharmaceuticals Company Information
6.4.2 Xellia Pharmaceuticals Description and Business Overview
6.4.3 Xellia Pharmaceuticals Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Xellia Pharmaceuticals Echinocandins Antifungal Drugs Product Portfolio
6.4.5 Xellia Pharmaceuticals Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Echinocandins Antifungal Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Hikma
6.6.1 Hikma Company Information
6.6.2 Hikma Description and Business Overview
6.6.3 Hikma Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hikma Echinocandins Antifungal Drugs Product Portfolio
6.6.5 Hikma Recent Developments/Updates
6.7 Apotex
6.7.1 Apotex Company Information
6.7.2 Apotex Description and Business Overview
6.7.3 Apotex Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Apotex Echinocandins Antifungal Drugs Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Fresenius
6.8.1 Fresenius Company Information
6.8.2 Fresenius Description and Business Overview
6.8.3 Fresenius Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Fresenius Echinocandins Antifungal Drugs Product Portfolio
6.8.5 Fresenius Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Company Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Echinocandins Antifungal Drugs Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 CTTQ
6.10.1 CTTQ Company Information
6.10.2 CTTQ Description and Business Overview
6.10.3 CTTQ Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CTTQ Echinocandins Antifungal Drugs Product Portfolio
6.10.5 CTTQ Recent Developments/Updates
6.11 QILU Pharmaceutical
6.11.1 QILU Pharmaceutical Company Information
6.11.2 QILU Pharmaceutical Description and Business Overview
6.11.3 QILU Pharmaceutical Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 QILU Pharmaceutical Echinocandins Antifungal Drugs Product Portfolio
6.11.5 QILU Pharmaceutical Recent Developments/Updates
6.12 BrightGene Bio-Medical Technology
6.12.1 BrightGene Bio-Medical Technology Company Information
6.12.2 BrightGene Bio-Medical Technology Description and Business Overview
6.12.3 BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Product Portfolio
6.12.5 BrightGene Bio-Medical Technology Recent Developments/Updates
6.13 Hansoh Pharmaceutical
6.13.1 Hansoh Pharmaceutical Company Information
6.13.2 Hansoh Pharmaceutical Description and Business Overview
6.13.3 Hansoh Pharmaceutical Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hansoh Pharmaceutical Echinocandins Antifungal Drugs Product Portfolio
6.13.5 Hansoh Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Echinocandins Antifungal Drugs Industry Chain Analysis
7.2 Echinocandins Antifungal Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Echinocandins Antifungal Drugs Production Mode & Process Analysis
7.4 Echinocandins Antifungal Drugs Sales and Marketing
7.4.1 Echinocandins Antifungal Drugs Sales Channels
7.4.2 Echinocandins Antifungal Drugs Distributors
7.5 Echinocandins Antifungal Drugs Customer Analysis
8 Echinocandins Antifungal Drugs Market Dynamics
8.1 Echinocandins Antifungal Drugs Industry Trends
8.2 Echinocandins Antifungal Drugs Market Drivers
8.3 Echinocandins Antifungal Drugs Market Challenges
8.4 Echinocandins Antifungal Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Astellas
Endo International
Xellia Pharmaceuticals
TEVA
Hikma
Apotex
Fresenius
Pfizer Inc
CTTQ
Qilu Pharmaceutical
BrightGene Bio-Medical Technology
Hansoh Pharmaceutical
List of Tables
 Table 1. Global Echinocandins Antifungal Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Echinocandins Antifungal Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Echinocandins Antifungal Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Echinocandins Antifungal Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Echinocandins Antifungal Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Echinocandins Antifungal Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Echinocandins Antifungal Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Echinocandins Antifungal Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Echinocandins Antifungal Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Echinocandins Antifungal Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Echinocandins Antifungal Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Echinocandins Antifungal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Echinocandins Antifungal Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Echinocandins Antifungal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Echinocandins Antifungal Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Echinocandins Antifungal Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Echinocandins Antifungal Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Echinocandins Antifungal Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Echinocandins Antifungal Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Echinocandins Antifungal Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Echinocandins Antifungal Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Echinocandins Antifungal Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Echinocandins Antifungal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Echinocandins Antifungal Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Echinocandins Antifungal Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Echinocandins Antifungal Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Echinocandins Antifungal Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Echinocandins Antifungal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Echinocandins Antifungal Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Echinocandins Antifungal Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Echinocandins Antifungal Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Echinocandins Antifungal Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Echinocandins Antifungal Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Echinocandins Antifungal Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Echinocandins Antifungal Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Echinocandins Antifungal Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Echinocandins Antifungal Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Echinocandins Antifungal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Echinocandins Antifungal Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Echinocandins Antifungal Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Echinocandins Antifungal Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Echinocandins Antifungal Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Echinocandins Antifungal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Echinocandins Antifungal Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Echinocandins Antifungal Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Echinocandins Antifungal Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Echinocandins Antifungal Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Echinocandins Antifungal Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Echinocandins Antifungal Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Echinocandins Antifungal Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Echinocandins Antifungal Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Echinocandins Antifungal Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Echinocandins Antifungal Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Echinocandins Antifungal Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Echinocandins Antifungal Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Echinocandins Antifungal Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Echinocandins Antifungal Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Echinocandins Antifungal Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Echinocandins Antifungal Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Echinocandins Antifungal Drugs Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Astellas Company Information
 Table 76. Astellas Description and Business Overview
 Table 77. Astellas Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Astellas Echinocandins Antifungal Drugs Product
 Table 79. Astellas Recent Developments/Updates
 Table 80. Endo International Company Information
 Table 81. Endo International Description and Business Overview
 Table 82. Endo International Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Endo International Echinocandins Antifungal Drugs Product
 Table 84. Endo International Recent Developments/Updates
 Table 85. Xellia Pharmaceuticals Company Information
 Table 86. Xellia Pharmaceuticals Description and Business Overview
 Table 87. Xellia Pharmaceuticals Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Xellia Pharmaceuticals Echinocandins Antifungal Drugs Product
 Table 89. Xellia Pharmaceuticals Recent Developments/Updates
 Table 90. Teva Company Information
 Table 91. Teva Description and Business Overview
 Table 92. Teva Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Echinocandins Antifungal Drugs Product
 Table 94. Teva Recent Developments/Updates
 Table 95. Hikma Company Information
 Table 96. Hikma Description and Business Overview
 Table 97. Hikma Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hikma Echinocandins Antifungal Drugs Product
 Table 99. Hikma Recent Developments/Updates
 Table 100. Apotex Company Information
 Table 101. Apotex Description and Business Overview
 Table 102. Apotex Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Apotex Echinocandins Antifungal Drugs Product
 Table 104. Apotex Recent Developments/Updates
 Table 105. Fresenius Company Information
 Table 106. Fresenius Description and Business Overview
 Table 107. Fresenius Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Fresenius Echinocandins Antifungal Drugs Product
 Table 109. Fresenius Recent Developments/Updates
 Table 110. Pfizer Company Information
 Table 111. Pfizer Description and Business Overview
 Table 112. Pfizer Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Pfizer Echinocandins Antifungal Drugs Product
 Table 114. Pfizer Recent Developments/Updates
 Table 115. CTTQ Company Information
 Table 116. CTTQ Description and Business Overview
 Table 117. CTTQ Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. CTTQ Echinocandins Antifungal Drugs Product
 Table 119. CTTQ Recent Developments/Updates
 Table 120. QILU Pharmaceutical Company Information
 Table 121. QILU Pharmaceutical Description and Business Overview
 Table 122. QILU Pharmaceutical Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. QILU Pharmaceutical Echinocandins Antifungal Drugs Product
 Table 124. QILU Pharmaceutical Recent Developments/Updates
 Table 125. BrightGene Bio-Medical Technology Company Information
 Table 126. BrightGene Bio-Medical Technology Description and Business Overview
 Table 127. BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Product
 Table 129. BrightGene Bio-Medical Technology Recent Developments/Updates
 Table 130. Hansoh Pharmaceutical Company Information
 Table 131. Hansoh Pharmaceutical Description and Business Overview
 Table 132. Hansoh Pharmaceutical Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Hansoh Pharmaceutical Echinocandins Antifungal Drugs Product
 Table 134. Hansoh Pharmaceutical Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Echinocandins Antifungal Drugs Distributors List
 Table 138. Echinocandins Antifungal Drugs Customers List
 Table 139. Echinocandins Antifungal Drugs Market Trends
 Table 140. Echinocandins Antifungal Drugs Market Drivers
 Table 141. Echinocandins Antifungal Drugs Market Challenges
 Table 142. Echinocandins Antifungal Drugs Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Echinocandins Antifungal Drugs
 Figure 2. Global Echinocandins Antifungal Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Echinocandins Antifungal Drugs Market Share by Type: 2024 & 2031
 Figure 4. Caspofungin Product Picture
 Figure 5. Micafungin Product Picture
 Figure 6. Anidulafungin Product Picture
 Figure 7. Global Echinocandins Antifungal Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Echinocandins Antifungal Drugs Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Drugstore
 Figure 11. Global Echinocandins Antifungal Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Echinocandins Antifungal Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Echinocandins Antifungal Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Echinocandins Antifungal Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 15. Echinocandins Antifungal Drugs Report Years Considered
 Figure 16. Echinocandins Antifungal Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Echinocandins Antifungal Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Echinocandins Antifungal Drugs Players: Market Share by Revenue in Echinocandins Antifungal Drugs in 2024
 Figure 19. Echinocandins Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Echinocandins Antifungal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Echinocandins Antifungal Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Echinocandins Antifungal Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. United States Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Echinocandins Antifungal Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Echinocandins Antifungal Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Echinocandins Antifungal Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Echinocandins Antifungal Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Echinocandins Antifungal Drugs Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Echinocandins Antifungal Drugs Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Echinocandins Antifungal Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Echinocandins Antifungal Drugs Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Echinocandins Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Echinocandins Antifungal Drugs by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Echinocandins Antifungal Drugs by Type (2020-2031)
 Figure 53. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Echinocandins Antifungal Drugs by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Echinocandins Antifungal Drugs by Application (2020-2031)
 Figure 56. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 57. Echinocandins Antifungal Drugs Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Echinocandins for Injection Market Research Report 2024
Global Echinocandins Market Research Report 2024
Global Cancidas Market Research Report 2024
Global Echinocandin B Market Research Report 2024
Global Azole Antifungals Market Research Report 2024
Global Anidulafungin for Injection Market Research Report 2024
Global Medical Antifungal Agent Market Research Report 2025
Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fluconazole Preparation Market Research Report 2024
Global Antifungal Drugs for Skin Market Research Report 2024
Global Anti fungal Drugs Market Insights Forecast to 2030
Global Anti Dermatomycosis Treatment Market Research Report 2025
Global Drugs for Vulvovaginal Candidiasis Market Research Report 2025
Fluconazole Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Posaconazole Market Research Report 2024
Global Anti Fungal Agents Market Insights Forecast to 2030
Global Antimycotic Medication Market Insights Forecast to 2030
Global Itraconazole Inhibitors Market Research Report 2024
Global Fungal Drugs for Treatment of Tinea Market Research Report 2025
Systemic Antifungals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Medication for Facial Features Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4D16704
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions